Home > Lectures > Lecture Details

Guidewire Catheter: John Simpson

By Paul Yock - Stanford
get flash player

Lecture Description

John Simpson, a Stanford trainee in cardiology, thought the catheter system didn't work so he worked in his kitchen in Menlo Park to develop a catheter that is easier to use. He used a guidewire to travel down into the coronary artery . With money from Fogarty and Ray Williams, an angel investor, he started a company called ACS, which grew into Guidant.

Course Index

  1. The Accidental Entrepreneur
  2. Biotech Bay: The Other Silicon Valley
  3. Biotech: Interface Between Industry and University
  4. Cardiovascular Disease vs. Bioterrorism
  5. Beginning of Less Invasive Cardiac Techniques: Charles Dotter
  6. History of Balloon Angioplasty Catheter: Thomas Fogarty
  7. Coronary Angioplasty: Andreas Geruntzig
  8. Guidewire Catheter: John Simpson
  9. Mentoring Changed My Life
  10. Testing Medical Devices and Overcoming FDA Hurdles
  11. Restentosis and Stents: Just in Time Design
  12. Using Stents as Drug Delivery System
  13. Opportunity: How to Cover Economic Loss from Stent Use?
  14. Medtech: What's Going on in Region and at Stanford
  15. Interdisciplinary Biomed Education and Clark Center at Stanford
  16. Identify the Need: Invention and Being Contrary
  17. MedTech: Keep it Simple
  18. Patents Dominate MedTech
  19. FDA and Medicare
  20. Think Big and Pay Close Attention to Market Assessment
  21. Envisioning the Future in Medtech: Go Where the Puck Will Be
  22. Who Does Non-surgical Procedures?
  23. Medical Inventions: Physicians and Entrepreneurs in Partnership
  24. How are Financials for Cardiac Surgery?
  25. Cost vs. Price for Medical Stents?
  26. Future of Robotics in Minimally Invasive Surgery?
  27. Attributes of a Successful Entrepreneur in MedTech
  28. What's the Future of Medical Diagnostics?
  29. Who is Leading the Stent Market Today?
  30. Startups: How to Avoid Being Squashed by Big Companies?
  31. Convergence and Drug Delivery
  32. Medical Devices and Nanotechnology
  33. Scaling Technologies to the Developing World